Barclays’s PetMed Express PETS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-57
| Closed | -$143 | – | 5568 |
|
|
2025
Q3 | $143 | Buy |
+57
| New | +$176 | ﹤0.01% | 5258 |
|
|
2024
Q2 | – | Sell |
-13,923
| Closed | -$66.7K | – | 5196 |
|
|
2024
Q1 | $66.7K | Sell |
13,923
-14,158
| -50% | -$82.3K | ﹤0.01% | 4553 |
|
|
2023
Q4 | $212K | Buy |
28,081
+20,928
| +293% | +$172K | ﹤0.01% | 4391 |
|
|
2023
Q3 | $73.3K | Sell |
7,153
-96,303
| -93% | -$1.19M | ﹤0.01% | 3708 |
|
|
2023
Q2 | $1.43M | Buy |
103,456
+53,131
| +106% | +$798K | ﹤0.01% | 2094 |
|
|
2023
Q1 | $817K | Buy |
50,325
+44,904
| +828% | +$846K | ﹤0.01% | 2891 |
|
|
2022
Q4 | $96K | Buy |
5,421
+4,565
| +533% | +$90.7K | ﹤0.01% | 4249 |
|
|
2022
Q3 | $17K | Sell |
856
-158
| -16% | -$3.35K | ﹤0.01% | 4120 |
|
|
2022
Q2 | $20K | Sell |
1,014
-2,410
| -70% | -$53.9K | ﹤0.01% | 4406 |
|
|
2022
Q1 | $88K | Sell |
3,424
-21,298
| -86% | -$552K | ﹤0.01% | 3846 |
|
|
2021
Q4 | $624K | Buy |
24,722
+7,708
| +45% | +$213K | ﹤0.01% | 3103 |
|
|
2021
Q3 | $456K | Sell |
17,014
-17,799
| -51% | -$513K | ﹤0.01% | 3236 |
|
|
2021
Q2 | $1.11M | Buy |
34,813
+8,345
| +32% | +$265K | ﹤0.01% | 2592 |
|
|
2021
Q1 | $931K | Sell |
26,468
-38,227
| -59% | -$1.33M | ﹤0.01% | 2825 |
|
|
2020
Q4 | $2.08M | Sell |
64,695
-17,304
| -21% | -$533K | ﹤0.01% | 2204 |
|
|
2020
Q3 | $2.59M | Buy |
81,999
+2,908
| +4% | +$96.3K | ﹤0.01% | 1876 |
|
|
2020
Q2 | $2.82M | Buy |
79,091
+30,283
| +62% | +$1.05M | ﹤0.01% | 1805 |
|
|
2020
Q1 | $1.4M | Sell |
48,808
-10,538
| -18% | -$276K | ﹤0.01% | 2614 |
|
|
2019
Q4 | $1.4M | Sell |
59,346
-12,771
| -18% | -$286K | ﹤0.01% | 3358 |
|
|
2019
Q3 | $1.3M | Buy |
72,117
+3,562
| +5% | +$58.8K | ﹤0.01% | 3394 |
|
|
2019
Q2 | $1.07M | Buy |
68,555
+36,462
| +114% | +$717K | ﹤0.01% | 3607 |
|
|
2019
Q1 | $731K | Buy |
32,093
+13,482
| +72% | +$304K | ﹤0.01% | 3745 |
|
|
2018
Q4 | $433K | Sell |
18,611
-11,053
| -37% | -$295K | ﹤0.01% | 3933 |
|
|
2018
Q3 | $979K | Buy |
29,664
+9,460
| +47% | +$354K | ﹤0.01% | 3643 |
|
|
2018
Q2 | $891K | Sell |
20,204
-27,524
| -58% | -$1.07M | ﹤0.01% | 3407 |
|
|
2018
Q1 | $1.99M | Buy |
47,728
+43,945
| +1,162% | +$2.03M | ﹤0.01% | 2462 |
|
|
2017
Q4 | $173K | Sell |
3,783
-10,623
| -74% | -$419K | ﹤0.01% | 4800 |
|
|
2017
Q3 | $477K | Buy |
14,406
+9,533
| +196% | +$388K | ﹤0.01% | 3679 |
|
|
2017
Q2 | $198K | Buy |
4,873
+61
| +1% | +$1.89K | ﹤0.01% | 4359 |
|
|
2017
Q1 | $97K | Buy |
4,812
+4,152
| +629% | +$87.8K | ﹤0.01% | 4897 |
|
|
2016
Q4 | $16K | Sell |
660
-2,143
| -76% | -$45.9K | ﹤0.01% | 5729 |
|
|
2016
Q3 | $57K | Buy |
2,803
+2,791
| +23,258% | +$56.2K | ﹤0.01% | 4898 |
|
|
2016
Q2 | $0 | Buy |
+12
| New | +$221 | ﹤0.01% | 6564 |
|
|
2015
Q4 | – | Sell |
-9,015
| Closed | -$145K | – | 6425 |
|
|
2015
Q3 | $145K | Sell |
9,015
-1,146
| -11% | -$19.2K | ﹤0.01% | 4370 |
|
|
2015
Q2 | $171K | Sell |
10,161
-638
| -6% | -$10.7K | ﹤0.01% | 4251 |
|
|
2015
Q1 | $173K | Sell |
10,799
-1,293
| -11% | -$20K | ﹤0.01% | 4455 |
|
|
2014
Q4 | $170K | Buy |
12,092
+355
| +3% | +$4.78K | ﹤0.01% | 4776 |
|
|
2014
Q3 | $152K | Sell |
11,737
-1,016
| -8% | -$14.2K | ﹤0.01% | 4979 |
|
|
2014
Q2 | $164K | Sell |
12,753
-3,573
| -22% | -$47.2K | ﹤0.01% | 5005 |
|
|
2014
Q1 | $210K | Buy |
16,326
+3,103
| +23% | +$43K | ﹤0.01% | 4751 |
|
|
2013
Q4 | $213K | Sell |
13,223
-24,280
| -65% | -$379K | ﹤0.01% | 4949 |
|
|
2013
Q3 | $600K | Buy |
37,503
+3,881
| +12% | +$60.5K | ﹤0.01% | 3908 |
|
|
2013
Q2 | $423K | Buy |
+33,622
| New | +$438K | ﹤0.01% | 4409 |
|
Other funds holding PETS
SPH
Barclays's PETS Position: Q4 2025 in Review
Barclays sold out of PetMed Express (PETS) in Q4 2025, closing a stake of 57 shares — an estimated $143 sold.
Barclays first reported a position in PETS in Q2 2013 and held it in 43 quarters. The position peaked at $2.82M in Q2 2020. 51 funds tracked by Wall St. Rank hold PETS as of Q4 2025.
- Barclays reported no remaining PetMed Express position as of Q4 2025 after selling out during the quarter.
- Barclays sold 57 PetMed Express shares in Q4 2025, an estimated $143.
- Barclays first reported a position in PetMed Express in Q2 2013 and held it in 43 quarters.
- Barclays's PetMed Express position peaked at $2.82M in Q2 2020.
- 51 funds tracked by Wall St. Rank held PetMed Express as of Q4 2025.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.